Sharon Johnson is to head Catalent's newly formed Quality, Product Development & Regulatory Affairs organization. In her new role she will oversee a global function that includes more than 1,500 scientists, quality professionals and regulatory affairs experts.

Prior to assuming her new responsibilities, Johnson had served as Catalent's Senior Vice President, Global Quality & Regulatory Affairs since 2009. She has more than thirty years of experience in the pharmaceutical industry, including API and multiple dosages forms, from discovery and launch of NCEs and life cycle management. Before joining Catalent, Johnson served as Vice President of Quality for GE Healthcare's Medical Diagnostic Division, having previously worked in roles of increasing responsibility for Baxter Healthcare and Sanofi Aventis.

Johnson holds a postgraduate Diploma in Industrial Pharmaceutical Studies with Distinction from Brighton University and a BS Honours degree in Biological Sciences/Microbiology from North East Surrey College of Technology.